Home
Balaxi Pharmaceuticals Ltd Share Price History
Balaxi Pharmaceuticals Ltd
NSE : 21 Feb, 2025
56.680.9 (1.6%)
Prev Close
55.8
Open Price
55.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
26408
Today's High / Low
58.0 / 55.0
52 WK High / Low
151.4 / 51.0
Market Price of Balaxi Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring Balaxi Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2019 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 6.47 |
| YoY Gr. | - |
| Net Profit (Cr.) | 2 |
| BVPS | 11.58 |
Key Financial Parameters
| Parameter | 2019 |
|---|---|
| Return on Capital Emp. % | 69.32 |
| Op. Profit Mgn % | 17.94 |
| Net Profit Mgn % | 14.49 |
| Debt to Equity % | 0 |
Latest Shareholding
Promoters Holdings Over Time
About Balaxi Pharmaceuticals Ltd
- Balaxi Ventures Limited was formerly incorporated in the name of 'The Anandam Rubber Company Limited' on September 28, 1942.
- The Company changed its name from 'The Anandam Rubber Company Limited' to 'Balaxi Ventures Limited' on August 08, 2017.
- The Company incorporated with a basic objective of running rubber and tea plantations and owns several plantations across South India. In year 1989 the company sold its entire plantations to meet the emerging business needs and started concentrating in Investments and trading.
- The company previously was a investment company, but the company during the financial year 2018-19 has commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG Products On 15 March 2017, Balaxi Overseas Private Limited (BOPL) entered into a Share Purchase Agreement (SPA) with the erstwhile promoters of Company (i.
Popular Search
FAQs for Balaxi Pharmaceuticals Ltd Share Price History
What are the key events that typically impact Balaxi Pharmaceuticals Ltd's share price history?
Key events that impact Balaxi Pharmaceuticals Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Balaxi Pharmaceuticals Ltd's share price history?
Stock splits reduce the nominal price of Balaxi Pharmaceuticals Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Balaxi Pharmaceuticals Ltd?
Dividends can influence Balaxi Pharmaceuticals Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Balaxi Pharmaceuticals Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Balaxi Pharmaceuticals Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Balaxi Pharmaceuticals Ltd’s share price history?
To understand Balaxi Pharmaceuticals Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
